1. Home
  2. ATYR vs IROQ Comparison

ATYR vs IROQ Comparison

Compare ATYR & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.73

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo IF Bancorp Inc.

IROQ

IF Bancorp Inc.

HOLD

Current Price

$26.90

Market Cap

84.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
IROQ
Founded
2005
1883
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
84.4M
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
ATYR
IROQ
Price
$0.73
$26.90
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
2.0M
2.2K
Earning Date
11-06-2025
01-29-2026
Dividend Yield
N/A
1.49%
EPS Growth
N/A
157.16
EPS
N/A
1.60
Revenue
$190,000.00
$27,979,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
$16.78
Revenue Growth
N/A
24.68
52 Week Low
$0.64
$22.84
52 Week High
$7.29
$27.01

Technical Indicators

Market Signals
Indicator
ATYR
IROQ
Relative Strength Index (RSI) 42.99 65.65
Support Level $0.70 $26.60
Resistance Level $0.76 $26.98
Average True Range (ATR) 0.04 0.21
MACD 0.01 0.03
Stochastic Oscillator 32.21 86.42

Price Performance

Historical Comparison
ATYR
IROQ

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.

Share on Social Networks: